| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $76.3M | -5.4% | -0.0% |
| Gross Profit | $40.1M | — | +10.6% |
| R&D Expense | $12.3M | -0.9% | -13.5% |
| SG&A Expense | $16.1M | +94.0% | +31.6% |
| Operating Income | -$17.5M | +52.8% | -27.9% |
| Income Tax | $41K | -49.4% | +108.6% |
| Net Income | -$22.2M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $40.3M | -20.5% | -87.7% |
| Short-term Investments | $51.2M | +9.9% | -13.1% |
| Accounts Receivable | $60.1M | -12.1% | +16.4% |
| Current Assets | $165.4M | -8.4% | -63.9% |
| Total Assets | $587.1M | -4.7% | -27.8% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$9.2M | — | — |
| Capital Expenditures | $695K | — | — |
| Investing Cash Flow | $35.2M | — | — |
| Financing Cash Flow | -$235.3M | — | — |
| Free Cash Flow | -$9.9M | — | — |
| -51.0% |
| EPS (Basic) | -$0.32 | +45.8% | -33.3% |
| EPS (Diluted) | -$0.32 | +45.8% | -33.3% |
| $87.9M |
| -11.1% |
| -72.9% |
| Long-term Debt | $153.1M | +0.1% | -55.6% |
| Total Liabilities | $255.2M | -5.0% | -44.3% |
| Stockholders' Equity | $331.9M | -4.5% | -6.5% |